209 related articles for article (PubMed ID: 30875061)
1. Skin and lung toxicity in synchronous bilateral breast cancer treated with volumetric-modulated arc radiotherapy: a mono-institutional experience.
Valli M; Cima S; Gaudino D; Cartolari R; Deantonio L; Frapolli M; Daniele D; Pesce GA; Martucci F; Azinwi NC; Bosetti D; Presilla S; Richetti A
Clin Transl Oncol; 2019 Nov; 21(11):1492-1498. PubMed ID: 30875061
[TBL] [Abstract][Full Text] [Related]
2. Synchronous bilateral breast cancer treated with a 3-week hypofractionated radiotherapy schedule: clinical and dosimetric outcomes.
Gadea J; Ortiz I; Roncero R; Alastuey I; Mestre F; Aymar N; Maturana JE; Garcia C; Mateu L; Pardo J
Clin Transl Oncol; 2021 Sep; 23(9):1915-1922. PubMed ID: 33830442
[TBL] [Abstract][Full Text] [Related]
3. Radiation therapy of synchronous bilateral breast carcinoma (SBBC) using multiple techniques.
Kim SJ; Lee MJ; Youn SM
Med Dosim; 2018 Spring; 43(1):55-68. PubMed ID: 28988893
[TBL] [Abstract][Full Text] [Related]
4. Accelerated hypofractionated adjuvant whole breast radiation with simultaneous integrated boost using volumetric modulated arc therapy for early breast cancer: A phase I/II dosimetric and clinical feasibility study from a tertiary cancer care centre of India.
Mondal D; Julka PK; Sharma DN; Jana M; Laviraj MA; Deo SV; Roy S; Guleria R; Rath GK
J Egypt Natl Canc Inst; 2017 Mar; 29(1):39-45. PubMed ID: 28343538
[TBL] [Abstract][Full Text] [Related]
5. Heart Dosimetry is Correlated With Risk of Radiation Pneumonitis After Lung-Sparing Hemithoracic Pleural Intensity Modulated Radiation Therapy for Malignant Pleural Mesothelioma.
Yorke ED; Jackson A; Kuo LC; Ojo A; Panchoo K; Adusumilli P; Zauderer MG; Rusch VW; Shepherd A; Rimner A
Int J Radiat Oncol Biol Phys; 2017 Sep; 99(1):61-69. PubMed ID: 28816162
[TBL] [Abstract][Full Text] [Related]
6. Phase I-II study of hypofractionated simultaneous integrated boost using volumetric modulated arc therapy for adjuvant radiation therapy in breast cancer patients: a report of feasibility and early toxicity results in the first 50 treatments.
Scorsetti M; Alongi F; Fogliata A; Pentimalli S; Navarria P; Lobefalo F; Garcia-Etienne C; Clivio A; Cozzi L; Mancosu P; Nicolini G; Vanetti E; Eboli M; Rossetti C; Rubino A; Sagona A; Arcangeli S; Gatzemeier W; Masci G; Torrisi R; Testori A; Alloisio M; Santoro A; Tinterri C
Radiat Oncol; 2012 Aug; 7():145. PubMed ID: 22929062
[TBL] [Abstract][Full Text] [Related]
7. [Preliminary results of whole breast helical tomotherapy with simultaneous integrated boost in the adjuvant treatment of breast cancer].
Liem X; Chira C; Fourquet A; Campana F; Peurien D; Fournier-Bidoz N; Kirova YM
Cancer Radiother; 2014 Jan; 18(1):15-22. PubMed ID: 24316350
[TBL] [Abstract][Full Text] [Related]
8. Critical Appraisal of the Risk of Secondary Cancer Induction From Breast Radiation Therapy With Volumetric Modulated Arc Therapy Relative to 3D Conformal Therapy.
Fogliata A; De Rose F; Franceschini D; Stravato A; Seppälä J; Scorsetti M; Cozzi L
Int J Radiat Oncol Biol Phys; 2018 Mar; 100(3):785-793. PubMed ID: 29249528
[TBL] [Abstract][Full Text] [Related]
9. Evaluation of optimal treatment planning for radiotherapy of synchronous bilateral breast cancer including regional lymph node irradiation.
Cho Y; Cho YJ; Chang WS; Kim JW; Choi WH; Lee IJ
Radiat Oncol; 2019 Apr; 14(1):56. PubMed ID: 30935400
[TBL] [Abstract][Full Text] [Related]
10. Synchronous bilateral breast cancer irradiation: clinical and dosimetrical issues using volumetric modulated arc therapy and simultaneous integrated boost.
Fiorentino A; Mazzola R; Naccarato S; Giaj-Levra N; Fersino S; Sicignano G; Tebano U; Ricchetti F; Ruggieri R; Alongi F
Radiol Med; 2017 Jun; 122(6):464-471. PubMed ID: 28224401
[TBL] [Abstract][Full Text] [Related]
11. Is helical tomotherapy-based intensity-modulated radiotherapy feasible and effective in bilateral synchronous breast cancer? A two-center experience.
Ekici K; Gokce T; Karadogan I; Fatma Eraslan A; Akcay C; Temelli O; Kaya Pepele E; Durmus Manalp F; Keles C; Mayadagli A
J BUON; 2016; 21(1):46-52. PubMed ID: 27061530
[TBL] [Abstract][Full Text] [Related]
12. [Importance of dosimetric factors predicting radiation toxicity in lung cancer treatment].
Letautiene SR; Valuckas KP
Medicina (Kaunas); 2006; 42(4):314-20. PubMed ID: 16687903
[TBL] [Abstract][Full Text] [Related]
13. Hypofractionated whole-breast radiation therapy: does breast size matter?
Hannan R; Thompson RF; Chen Y; Bernstein K; Kabarriti R; Skinner W; Chen CC; Landau E; Miller E; Spierer M; Hong L; Kalnicki S
Int J Radiat Oncol Biol Phys; 2012 Nov; 84(4):894-901. PubMed ID: 22543209
[TBL] [Abstract][Full Text] [Related]
14. First clinical report of helical tomotherapy with simultaneous integrated boost for synchronous bilateral breast cancer.
Wadasadawala T; Jain S; Paul S; Phurailatpam R; Joshi K; Popat P; Tandon S; Alahari A; Sarin R
Br J Radiol; 2017 Aug; 90(1077):20170152. PubMed ID: 28707988
[TBL] [Abstract][Full Text] [Related]
15. Pulmonary changes after radiotherapy for conservative treatment of breast cancer: a prospective study.
Krengli M; Sacco M; Loi G; Masini L; Ferrante D; Gambaro G; Ronco M; Magnani C; Carriero A
Int J Radiat Oncol Biol Phys; 2008 Apr; 70(5):1460-7. PubMed ID: 17931797
[TBL] [Abstract][Full Text] [Related]
16. Comparison of butterfly volumetric modulated arc therapy to full arc with or without deep inspiration breath hold for the treatment of mediastinal lymphoma.
Starke A; Bowden J; Lynn R; Hall K; Hudson K; Rato A; Aldridge E; Robb D; Steele P; Brady J; Mikhaeel NG
Radiother Oncol; 2018 Dec; 129(3):449-455. PubMed ID: 30245037
[TBL] [Abstract][Full Text] [Related]
17. Helical tomotherapy for bilateral breast cancer: Clinical experience.
Kaidar-Person O; Kostich M; Zagar TM; Jones E; Gupta G; Mavroidis P; Das SK; Marks LB
Breast; 2016 Aug; 28():79-83. PubMed ID: 27253152
[TBL] [Abstract][Full Text] [Related]
18. Hypofractionated volumetric modulated arc therapy in ductal carcinoma in situ: toxicity and cosmetic outcome from a prospective series.
De Rose F; Fogliata A; Franceschini D; Iftode C; Torrisi R; Masci G; Sagona A; Tinterri C; Testori A; Gatzemeier W; Fernandes B; Rahal D; Cozzi L; Santoro A; Scorsetti M
Br J Radiol; 2018 May; 91(1085):20170634. PubMed ID: 29322827
[TBL] [Abstract][Full Text] [Related]
19. Tomotherapy as an adjuvant treatment for gastroesophageal junction and stomach cancer may reduce bowel and bone marrow toxicity compared to intensity-modulated radiotherapy and volumetric-modulated arc therapy.
Wang X; Tian Y; Tang Y; Hu ZH; Zhang JJ; Fu GS; Ma P; Ren H; Zhang T; Li N; Liu WY; Fang H; Li YX; Jin J
Oncotarget; 2017 Jun; 8(24):39727-39735. PubMed ID: 28061474
[TBL] [Abstract][Full Text] [Related]
20. Long term results of a phase II trial of hypofractionated adjuvant radiotherapy for early-stage breast cancer with volumetric modulated arc therapy and simultaneous integrated boost.
Franceschini D; Fogliata A; Spoto R; Dominici L; Lo Faro L; Franzese C; Comito T; Lobefalo F; Reggiori G; Cozzi L; Sagona A; Gentile D; Scorsetti M
Radiother Oncol; 2021 Nov; 164():50-56. PubMed ID: 34537289
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
